255 related articles for article (PubMed ID: 34796406)
21. Characterization and antioxidant activity of the complexes of tertiary butylhydroquinone with β-cyclodextrin and its derivatives.
Pu H; Sun Q; Tang P; Zhao L; Li Q; Liu Y; Li H
Food Chem; 2018 Sep; 260():183-192. PubMed ID: 29699660
[TBL] [Abstract][Full Text] [Related]
22. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
Jambhekar S; Casella R; Maher T
Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
[TBL] [Abstract][Full Text] [Related]
23. Daidzein/cyclodextrin/hydrophilic polymer ternary systems.
Borghetti GS; Pinto AP; Lula IS; Sinisterra RD; Teixeira HF; Bassani VL
Drug Dev Ind Pharm; 2011 Aug; 37(8):886-93. PubMed ID: 21247375
[TBL] [Abstract][Full Text] [Related]
24. Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation.
Ficarra R; Tommasini S; Raneri D; Calabrò ML; Di Bella MR; Rustichelli C; Gamberini MC; Ficarra P
J Pharm Biomed Anal; 2002 Aug; 29(6):1005-14. PubMed ID: 12110385
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical characterization and in vitro biological evaluation of solid compounds from furazolidone-based cyclodextrins for use as leishmanicidal agents.
Carvalho SG; Cipriano DF; de Freitas JCC; Junior MÂS; Ocaris ERY; Teles CBG; de Jesus Gouveia A; Rodrigues RP; Zanini MS; Villanova JCO
Drug Deliv Transl Res; 2020 Dec; 10(6):1788-1809. PubMed ID: 32803562
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C
J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543
[TBL] [Abstract][Full Text] [Related]
27. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
[TBL] [Abstract][Full Text] [Related]
28. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
Tang P; Li S; Wang L; Yang H; Yan J; Li H
Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
[TBL] [Abstract][Full Text] [Related]
29. Inclusion complexes of phosphorylated daidzein derivatives with β-cyclodextrin: Preparation and inclusion behavior study.
Xiao Y; Yang L; Mao P; Yuan J; Deng Y; Qu L
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Jan; 85(1):298-302. PubMed ID: 22041503
[TBL] [Abstract][Full Text] [Related]
30. Encapsulation of catechin into nano-cyclodextrin-metal-organic frameworks: Preparation, characterization, and evaluation of storage stability and bioavailability.
Jiang L; Wang F; Du M; Xie C; Xie X; Zhang H; Meng X; Li A; Deng T
Food Chem; 2022 Nov; 394():133553. PubMed ID: 35753258
[TBL] [Abstract][Full Text] [Related]
31. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes.
Wang L; Li S; Tang P; Yan J; Xu K; Li H
Carbohydr Polym; 2015 Sep; 129():9-16. PubMed ID: 26050882
[TBL] [Abstract][Full Text] [Related]
32. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
33. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
Patel R; Patel M
Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310
[TBL] [Abstract][Full Text] [Related]
34. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
[TBL] [Abstract][Full Text] [Related]
35. Encapsulating quercetin in cyclodextrin metal-organic frameworks improved its solubility and bioavailability.
Wang Z; Ma Y; Jiang Y; Zhou F; Wu Y; Jiang H; Wang R; Xu Q; Hua C
J Sci Food Agric; 2022 Jul; 102(9):3887-3896. PubMed ID: 34952968
[TBL] [Abstract][Full Text] [Related]
36. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.
Bayomi MA; Abanumay KA; Al-Angary AA
Int J Pharm; 2002 Aug; 243(1-2):107-17. PubMed ID: 12176299
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical [corrected] properties of the inclusion complex of puerarin and glucosyl-β-cyclodextrin.
Liu B; Zhao J; Liu Y; Zhu X; Zeng J
J Agric Food Chem; 2012 Dec; 60(51):12501-7. PubMed ID: 23215052
[TBL] [Abstract][Full Text] [Related]
38. Solvent-Free Loading of Vitamin A Palmitate into β-Cyclodextrin Metal-Organic Frameworks for Stability Enhancement.
Zhang Y; Chen J; Zhang Z; Zhu H; Ma W; Zhao X; Wang M; Wang C; Chen W; Naeem A; Zhang J; Guo T; Wu L
AAPS PharmSciTech; 2023 Jun; 24(5):136. PubMed ID: 37308749
[TBL] [Abstract][Full Text] [Related]
39. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
40. In-vitro dissolution and microbial inhibition studies on anticancer drug etoposide with β-cyclodextrin.
Arumugam SP; Balakrishnan SB; Ganesan V; Munisamy M; Kuppu SV; Narayanan V; Baskaralingam V; Jeyachandran S; Thambusamy S
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():96-105. PubMed ID: 31147064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
